Results 171 to 180 of about 533,744 (303)

Correction to "Learning Curves in Prospective Life Cycle Assessment". [PDF]

Environ Sci Technol
van der Hulst MK, Hauck M, Hoeks S, van Zelm R, Huijbregts MAJ.   +4 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

It is time to develop characterization factors for terrestrial plastic pollution impacts on ecosystems in life cycle impact assessment: a systematic review identifying knowledge gaps

Life cycle assessment (LCA) can help evaluate the environmental impacts of processes and products over their life cycle. However, the LCA community largely agrees that current assessment methods need further development to consider plastic pollution ...
Vijver, Martina G., Galafton, C., Galafton, Christina, Thonemann, Nils, Thonemann, N., Vijver, M.G.   +5 more
core   +1 more source

Allocation in field crop and livestock life cycle assessment. [PDF]

Int J Life Cycle Assess
Bamber N, Kroebel R, Pelletier N.
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Single issue assessment VS full Life Cycle Assessment: the case of a monocrystalline PV pannel

, 2011
The consequences of climate change and lack of sustainability of current energy models are debated at international level. The scientific community, to support the development of sustainable policies in this area, has for years invested in the ...
MANZARDO, ALESSANDRO, NIERO, MONIA, SCIPIONI, ANTONIO, Levorato B., MAZZI, ANNA   +4 more
core  

Net Carbon Sink Potential of Porous Vegetated Concrete: A Life-Cycle Assessment. [PDF]

Materials (Basel)
Ren H, Lu L, Tang B, Li T.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Carbon Footprint of Antibody-Based Drugs and Biologics Using Hybrid Life Cycle Assessment. [PDF]

Clin Pharmacol Ther
Taillemite S, Fenelon M, Scherlinger M, Piffoux M.   +3 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source